National Heart, Lung, and Blood Institute Announces Phase II and Phase III Clinical Trials for Lung Diseases

Summary

The National Heart, Lung, and Blood Institute is conducting Phase II and Phase III clinical trials for lung diseases, as part of its ongoing efforts to improve treatment options for patients suffering from respiratory conditions.